Webinar | Intra-Aortic Balloon Pumps (IABP)| December 22, 2015

Webinar: Hemodynamics of Counterpulsation

This webinar is sponsored by Maquet

IABP

The webinar "Hemodynamics of Counterpulsation" explained how the intra-aortic balloon pump (IABP) can increase diastolic aortic pressure and augment coronary blood flow and reduce aortic and left ventricular systolic pressure or afterload. This education offering provides a review of the physiologic benefits, evaluation of patient response, discusses how patients may derive the most benefit and offers practical technical components to optimize IABP therapy.


The live webinar was Jan. 28, 2016, but a recorded version is available on demand.  
Register for the on demand webinar


Statement of Purpose/Need: 

The Intra-aortic balloon pump (IABP) has been the first-line choice for mechanical circulatory support around the world due to its clinical efficacy, safety profile across a broad range of patient care scenarios, and low cost. IABP therapy is the most widely used nondurable mechanical circulatory support device (MCS), with more than 160,000 IAB catheters placed globally per a year. The primary goals of the IABP are to (1) increase diastolic aortic pressure and augment coronary blood flow, and (2) reduce aortic and left ventricular systolic pressure or afterload. This education offering will provide a review of the physiologic benefits, evaluate patient response, discuss what patients may derive the most benefit and practical technical components to optimize IABP therapy.


After completing the webinar, the participant should be able to::


• Assess the physiologic effects of Intra-aortic balloon counterpulsation (IABP) therapy

• Understand the clinical utility of IAB use

• Describe the factors that effect IAB catheter performance and benefits of larger-capacity IAB catheters


Speaker:



Atman P. Shah 

Associate Professor of Medicine 

Clinical Director, Section of Cardiology 

Co-Director, Cardiac Catheterization Laboratory


Atman P. Shah, M.D., is an interventional cardiologist at the University of Chicago. Shah's research efforts focus on improving survival rates in patients who have experienced a cardiac arrest or an acute myocardial infarction (heart attack). Additionally, he studies new therapies that can help save heart muscle during a heart attack. Shah is the primary investigator on a number of large multicenter clinical trials investigating novel medications and devices designed to improve the quality of life in patients with coronary artery and structural heart disease. Shah has authored six book chapters and more than 50 abstracts and publications. A dedicated educator, he trains medical students, residents and fellows. He is the recipient of several honors and awards for clinical service, leadership and teaching.


About Maquet Medical Systems

Since 1838, the Maquet brand has been synonymous with high-quality products for patient-focused care. Maquet is a global leader in medical systems that advance surgical interventions, cardiovascular procedures and critical care. Cardiovascular specialties include intra-aortic balloon counterpulsation therapy for cardiac assist; coronary artery bypass surgery; aortic and peripheral vascular surgery; and extracorporeal circulation. Maquet continuously strives to develop innovative technologies that enhance clinical expertise and improve healthcare economics, while also enabling medical professionals to achieve the best possible outcomes for all patients.


For more information please visit www.maquet.com



Register for the on demand webinar


Related Content

Sponsored Content | Videos | Angiography| June 22, 2017
Shimadzu Medical Systems hghlighted new features of its Trinias Interventional X-ray line at the America College of C
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
BioTrace Medical's Tempo Lead Shows Stability and Safety in Real-World Performance
News | Leads Implantable Devices| June 20, 2017
BioTrace Medical Inc. announced that the company’s Tempo Temporary Pacing Lead was featured in an oral presentation and...
Stroke2prevent Receives FDA 510(k) Clearance for A-View
Technology | Ultrasound Transesophageal echo (TEE)| June 20, 2017
June 20, 2017 — Dutch medical device company Stroke2prevent BV recently announced it has received U.S.
IABP recall for Maquet, Datascope intra-aortic balloon pump CS100 and CS300

The Datascope CS300 IABP console.

News | Hemodynamic Support Devices| June 20, 2017
June 20, 2017 — The U.S.
Sponsored Content | Videos | Cardiovascular Ultrasound| June 15, 2017
Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke Univer
radial access, transradial access trial using anticoagulants
News | Radial Access| June 15, 2017
June 15, 2017 — In patients undergoing t...
Mitral Valve regurgitation showed on an echocardiogram, cardiac ultrasound

Mitral valve regurgitation showed on an echocardiogram. Image from Toshiba.

News | Heart Valve Technology| June 15, 2017
June 15, 2017 — 4C Medical Technologies Inc., a developer of minimally invasive therapies for structural heart diseas
Sponsored Content | Videos | Heart Valve Technology| June 14, 2017
A discussion with Rebecca Hahn, M.D., FASE, director of interventional echocardiography and professor of medicine at
Overlay Init